0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Lung Tumor Embolization Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-20U11237
Home | Market Reports | Health| Health Conditions| Cancer
Global Lung Tumor Embolization Market Research Report 2022
BUY CHAPTERS

Global Lung Tumor Embolization Market Research Report 2025

Code: QYRE-Auto-20U11237
Report
March 2025
Pages:67
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Lung Tumor Embolization Market Size

The global market for Lung Tumor Embolization was valued at US$ 1447 million in the year 2024 and is projected to reach a revised size of US$ 2830 million by 2031, growing at a CAGR of 10.2% during the forecast period.

Lung Tumor Embolization Market

Lung Tumor Embolization Market

Transcatheter bronchial arterial chemoembolization is a minimally invasive operation. To put it simply, in the case of no operation, a tiny channel with a diameter of about 2 mm is made on the skin. Under the guidance of angiography machine, the tumor blood supply vessels are found and then the chemotherapy drugs are infused through the catheter, and then the tumor blood vessel is embolized with embolization agent to block the tumor blood supply. For the tumor is to kill (high concentration of anticancer drugs) + "starve to death (blocking tumor blood vessels) double treatment of the tumor, the local lesions for the least trauma treatment method.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Lung Tumor Embolization, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lung Tumor Embolization.
The Lung Tumor Embolization market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lung Tumor Embolization market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lung Tumor Embolization companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Lung Tumor Embolization Market Report

Report Metric Details
Report Name Lung Tumor Embolization Market
Accounted market size in year US$ 1447 million
Forecasted market size in 2031 US$ 2830 million
CAGR 10.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Inari Medical, Penumbra, Tendfo, Medtronic, Olympus
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Lung Tumor Embolization company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Lung Tumor Embolization Market growing?

Ans: The Lung Tumor Embolization Market witnessing a CAGR of 10.2% during the forecast period 2025-2031.

What is the Lung Tumor Embolization Market size in 2031?

Ans: The Lung Tumor Embolization Market size in 2031 will be US$ 2830 million.

Who are the main players in the Lung Tumor Embolization Market report?

Ans: The main players in the Lung Tumor Embolization Market are Inari Medical, Penumbra, Tendfo, Medtronic, Olympus

What are the Application segmentation covered in the Lung Tumor Embolization Market report?

Ans: The Applications covered in the Lung Tumor Embolization Market report are Hospitals, Ambulatory Surgical Centers

What are the Type segmentation covered in the Lung Tumor Embolization Market report?

Ans: The Types covered in the Lung Tumor Embolization Market report are Transarterial chemoembolization (TACE), Transarterial Radioembolization (TARE), Others

Recommended Reports

Lung Oncology Devices

Cancer Embolization

Cancer Therapies Market

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lung Tumor Embolization Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Transarterial chemoembolization (TACE)
1.2.3 Transarterial Radioembolization (TARE)
1.2.4 Others
1.3 Market by Application
1.3.1 Global Lung Tumor Embolization Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lung Tumor Embolization Market Perspective (2020-2031)
2.2 Global Lung Tumor Embolization Growth Trends by Region
2.2.1 Global Lung Tumor Embolization Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Lung Tumor Embolization Historic Market Size by Region (2020-2025)
2.2.3 Lung Tumor Embolization Forecasted Market Size by Region (2026-2031)
2.3 Lung Tumor Embolization Market Dynamics
2.3.1 Lung Tumor Embolization Industry Trends
2.3.2 Lung Tumor Embolization Market Drivers
2.3.3 Lung Tumor Embolization Market Challenges
2.3.4 Lung Tumor Embolization Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lung Tumor Embolization Players by Revenue
3.1.1 Global Top Lung Tumor Embolization Players by Revenue (2020-2025)
3.1.2 Global Lung Tumor Embolization Revenue Market Share by Players (2020-2025)
3.2 Global Lung Tumor Embolization Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Lung Tumor Embolization Revenue
3.4 Global Lung Tumor Embolization Market Concentration Ratio
3.4.1 Global Lung Tumor Embolization Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lung Tumor Embolization Revenue in 2024
3.5 Global Key Players of Lung Tumor Embolization Head office and Area Served
3.6 Global Key Players of Lung Tumor Embolization, Product and Application
3.7 Global Key Players of Lung Tumor Embolization, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Lung Tumor Embolization Breakdown Data by Type
4.1 Global Lung Tumor Embolization Historic Market Size by Type (2020-2025)
4.2 Global Lung Tumor Embolization Forecasted Market Size by Type (2026-2031)
5 Lung Tumor Embolization Breakdown Data by Application
5.1 Global Lung Tumor Embolization Historic Market Size by Application (2020-2025)
5.2 Global Lung Tumor Embolization Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Lung Tumor Embolization Market Size (2020-2031)
6.2 North America Lung Tumor Embolization Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Lung Tumor Embolization Market Size by Country (2020-2025)
6.4 North America Lung Tumor Embolization Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lung Tumor Embolization Market Size (2020-2031)
7.2 Europe Lung Tumor Embolization Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Lung Tumor Embolization Market Size by Country (2020-2025)
7.4 Europe Lung Tumor Embolization Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lung Tumor Embolization Market Size (2020-2031)
8.2 Asia-Pacific Lung Tumor Embolization Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Lung Tumor Embolization Market Size by Region (2020-2025)
8.4 Asia-Pacific Lung Tumor Embolization Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Lung Tumor Embolization Market Size (2020-2031)
9.2 Latin America Lung Tumor Embolization Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Lung Tumor Embolization Market Size by Country (2020-2025)
9.4 Latin America Lung Tumor Embolization Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lung Tumor Embolization Market Size (2020-2031)
10.2 Middle East & Africa Lung Tumor Embolization Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Lung Tumor Embolization Market Size by Country (2020-2025)
10.4 Middle East & Africa Lung Tumor Embolization Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Inari Medical
11.1.1 Inari Medical Company Details
11.1.2 Inari Medical Business Overview
11.1.3 Inari Medical Lung Tumor Embolization Introduction
11.1.4 Inari Medical Revenue in Lung Tumor Embolization Business (2020-2025)
11.1.5 Inari Medical Recent Development
11.2 Penumbra
11.2.1 Penumbra Company Details
11.2.2 Penumbra Business Overview
11.2.3 Penumbra Lung Tumor Embolization Introduction
11.2.4 Penumbra Revenue in Lung Tumor Embolization Business (2020-2025)
11.2.5 Penumbra Recent Development
11.3 Tendfo
11.3.1 Tendfo Company Details
11.3.2 Tendfo Business Overview
11.3.3 Tendfo Lung Tumor Embolization Introduction
11.3.4 Tendfo Revenue in Lung Tumor Embolization Business (2020-2025)
11.3.5 Tendfo Recent Development
11.4 Medtronic
11.4.1 Medtronic Company Details
11.4.2 Medtronic Business Overview
11.4.3 Medtronic Lung Tumor Embolization Introduction
11.4.4 Medtronic Revenue in Lung Tumor Embolization Business (2020-2025)
11.4.5 Medtronic Recent Development
11.5 Olympus
11.5.1 Olympus Company Details
11.5.2 Olympus Business Overview
11.5.3 Olympus Lung Tumor Embolization Introduction
11.5.4 Olympus Revenue in Lung Tumor Embolization Business (2020-2025)
11.5.5 Olympus Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Lung Tumor Embolization Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Transarterial chemoembolization (TACE)
 Table 3. Key Players of Transarterial Radioembolization (TARE)
 Table 4. Key Players of Others
 Table 5. Global Lung Tumor Embolization Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Lung Tumor Embolization Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Lung Tumor Embolization Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Lung Tumor Embolization Market Share by Region (2020-2025)
 Table 9. Global Lung Tumor Embolization Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Lung Tumor Embolization Market Share by Region (2026-2031)
 Table 11. Lung Tumor Embolization Market Trends
 Table 12. Lung Tumor Embolization Market Drivers
 Table 13. Lung Tumor Embolization Market Challenges
 Table 14. Lung Tumor Embolization Market Restraints
 Table 15. Global Lung Tumor Embolization Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Lung Tumor Embolization Market Share by Players (2020-2025)
 Table 17. Global Top Lung Tumor Embolization Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Tumor Embolization as of 2024)
 Table 18. Ranking of Global Top Lung Tumor Embolization Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Lung Tumor Embolization Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Lung Tumor Embolization, Headquarters and Area Served
 Table 21. Global Key Players of Lung Tumor Embolization, Product and Application
 Table 22. Global Key Players of Lung Tumor Embolization, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Lung Tumor Embolization Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Lung Tumor Embolization Revenue Market Share by Type (2020-2025)
 Table 26. Global Lung Tumor Embolization Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Lung Tumor Embolization Revenue Market Share by Type (2026-2031)
 Table 28. Global Lung Tumor Embolization Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Lung Tumor Embolization Revenue Market Share by Application (2020-2025)
 Table 30. Global Lung Tumor Embolization Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Lung Tumor Embolization Revenue Market Share by Application (2026-2031)
 Table 32. North America Lung Tumor Embolization Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Lung Tumor Embolization Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Lung Tumor Embolization Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Lung Tumor Embolization Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Lung Tumor Embolization Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Lung Tumor Embolization Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Lung Tumor Embolization Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Lung Tumor Embolization Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Lung Tumor Embolization Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Lung Tumor Embolization Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Lung Tumor Embolization Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Lung Tumor Embolization Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Lung Tumor Embolization Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Lung Tumor Embolization Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Lung Tumor Embolization Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Inari Medical Company Details
 Table 48. Inari Medical Business Overview
 Table 49. Inari Medical Lung Tumor Embolization Product
 Table 50. Inari Medical Revenue in Lung Tumor Embolization Business (2020-2025) & (US$ Million)
 Table 51. Inari Medical Recent Development
 Table 52. Penumbra Company Details
 Table 53. Penumbra Business Overview
 Table 54. Penumbra Lung Tumor Embolization Product
 Table 55. Penumbra Revenue in Lung Tumor Embolization Business (2020-2025) & (US$ Million)
 Table 56. Penumbra Recent Development
 Table 57. Tendfo Company Details
 Table 58. Tendfo Business Overview
 Table 59. Tendfo Lung Tumor Embolization Product
 Table 60. Tendfo Revenue in Lung Tumor Embolization Business (2020-2025) & (US$ Million)
 Table 61. Tendfo Recent Development
 Table 62. Medtronic Company Details
 Table 63. Medtronic Business Overview
 Table 64. Medtronic Lung Tumor Embolization Product
 Table 65. Medtronic Revenue in Lung Tumor Embolization Business (2020-2025) & (US$ Million)
 Table 66. Medtronic Recent Development
 Table 67. Olympus Company Details
 Table 68. Olympus Business Overview
 Table 69. Olympus Lung Tumor Embolization Product
 Table 70. Olympus Revenue in Lung Tumor Embolization Business (2020-2025) & (US$ Million)
 Table 71. Olympus Recent Development
 Table 72. Research Programs/Design for This Report
 Table 73. Key Data Information from Secondary Sources
 Table 74. Key Data Information from Primary Sources
 Table 75. Authors List of This Report


List of Figures
 Figure 1. Lung Tumor Embolization Picture
 Figure 2. Global Lung Tumor Embolization Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Lung Tumor Embolization Market Share by Type: 2024 VS 2031
 Figure 4. Transarterial chemoembolization (TACE) Features
 Figure 5. Transarterial Radioembolization (TARE) Features
 Figure 6. Others Features
 Figure 7. Global Lung Tumor Embolization Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Lung Tumor Embolization Market Share by Application: 2024 VS 2031
 Figure 9. Hospitals Case Studies
 Figure 10. Ambulatory Surgical Centers Case Studies
 Figure 11. Lung Tumor Embolization Report Years Considered
 Figure 12. Global Lung Tumor Embolization Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Lung Tumor Embolization Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Lung Tumor Embolization Market Share by Region: 2024 VS 2031
 Figure 15. Global Lung Tumor Embolization Market Share by Players in 2024
 Figure 16. Global Top Lung Tumor Embolization Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Tumor Embolization as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Lung Tumor Embolization Revenue in 2024
 Figure 18. North America Lung Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Lung Tumor Embolization Market Share by Country (2020-2031)
 Figure 20. United States Lung Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Lung Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Lung Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Lung Tumor Embolization Market Share by Country (2020-2031)
 Figure 24. Germany Lung Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Lung Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Lung Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Lung Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Lung Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Lung Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Lung Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Lung Tumor Embolization Market Share by Region (2020-2031)
 Figure 32. China Lung Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Lung Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Lung Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Lung Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Lung Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Lung Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Lung Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Lung Tumor Embolization Market Share by Country (2020-2031)
 Figure 40. Mexico Lung Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Lung Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Lung Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Lung Tumor Embolization Market Share by Country (2020-2031)
 Figure 44. Turkey Lung Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Lung Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Lung Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Inari Medical Revenue Growth Rate in Lung Tumor Embolization Business (2020-2025)
 Figure 48. Penumbra Revenue Growth Rate in Lung Tumor Embolization Business (2020-2025)
 Figure 49. Tendfo Revenue Growth Rate in Lung Tumor Embolization Business (2020-2025)
 Figure 50. Medtronic Revenue Growth Rate in Lung Tumor Embolization Business (2020-2025)
 Figure 51. Olympus Revenue Growth Rate in Lung Tumor Embolization Business (2020-2025)
 Figure 52. Bottom-up and Top-down Approaches for This Report
 Figure 53. Data Triangulation
 Figure 54. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28I6901
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22R9736
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29A2598
Tue Sep 09 00:00:00 UTC 2025

Add to Cart